Global Oligonucleotide synthesis Market

Oligonucleotide Synthesis Market Size, Share, Growth Analysis, By End-use(Academic Research Institutes, Diagnostic Laboratories), By Application(PCR Primers, PCR Assays and Panels) - Industry Forecast 2024-2031


Report ID: SQMIG35H2107 | Region: Global | Published Date: April, 2024
Pages: 219 | Tables: 67 | Figures: 75

Oligonucleotide Synthesis Market Insights

Global Oligonucleotide Synthesis Market size was valued at USD 4.60 billion in 2022 and is poised to grow from USD 5.16 billion in 2023 to USD 12.86 billion by 2031, at a CAGR of 12.10% during the forecast period (2024-2031).

The purpose of the oligonucleotide synthesis market is to provide researchers, scientists, and manufacturers with custom-made and pre-manufactured oligonucleotides for various applications, including gene synthesis, PCR, DNA sequencing, diagnostics, and therapeutics. The increasing demand for synthetic biology and personalized medicine is the primary driving factor for the oligonucleotide synthesis market. The increasing prevalence of cancer and genetic disorders is also boosting the demand for oligonucleotides in the market. The oligonucleotide synthesis market faces several challenges, including quality control, regulatory compliance, and ethical concerns related to gene synthesis. The increasing complexity of oligonucleotide synthesis and the need for specialized equipment and expertise pose significant challenges to market players. The oligonucleotide synthesis market presents several opportunities for market players, including the development of new and innovative oligonucleotide synthesis technologies, the expansion of the application areas for oligonucleotides, and the increasing demand for personalized medicine and gene therapy. The oligonucleotide synthesis market is expected to continue its growth trajectory in the coming years, driven by the increasing demand for synthetic biology and personalized medicine. However, the market may face challenges related to cost, technical expertise, quality control, and regulatory compliance.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Oligonucleotide Synthesis Market size was valued at USD 4.60 billion in 2022 and is poised to grow from USD 5.16 billion in 2023 to USD 12.86 billion by 2031, at a CAGR of 12.10% during the forecast period (2024-2031).

The oligonucleotide synthesis market is highly competitive and fragmented, with a large number of players operating in the market. The oligonucleotide synthesis market is driven by strategic initiatives such as collaborations, partnerships, and mergers and acquisitions. The oligonucleotide synthesis market is expected to witness intense competition among players, with a focus on innovation, product differentiation, and expansion of geographical presence. 'Agilent Technologies, Inc. (US)', 'BioAutomation Corporation (US)', 'Biosearch Technologies, Inc. (US)', 'Biolytic Lab Performance Inc. (Canada)', 'Eurofins Genomics LLC (US)', 'General Electric Company (US)', 'GenScript Biotech Corporation (China)', 'Integrated DNA Technologies, Inc. (US)', 'Kaneka Eurogentec S.A. (Belgium)', 'LGC Limited (UK)', 'Merck KGaA (Germany)', 'Nitto Denko Avecia Inc. (US)', 'Thermo Fisher Scientific Inc. (US)', 'TriLink BioTechnologies, LLC (US)', 'Twist Bioscience Corporation (US)', 'ATDBio Ltd. (UK)', 'Axil Scientific Pte Ltd. (Singapore)', 'Biogen International GmbH (Switzerland)', 'Biomer Technology LLC (US)', 'Bio-Synthesis, Inc. (US)'

The growing demand for oligonucleotides in drug development and diagnostics is a key driver of the oligonucleotide synthesis market. PCR primers, antisense oligonucleotides, and siRNA are just a few examples of oligonucleotides that are widely used in drug development and diagnostics.

Increasing Demand for Customized Oligonucleotides: There has been a growing demand for customized oligonucleotides, which are tailored to specific applications. Customized oligonucleotides are used in various applications, including research, diagnostics, and therapeutics. The growing demand for customized oligonucleotides is attributed to the increasing use of oligonucleotides in drug discovery and development, genetic testing, and personalized medicine. For instance, Integrated DNA Technologies, a leading provider of customized oligonucleotides, offers a wide range of oligonucleotides for research, diagnostics, and therapeutic applications.

North America dominated the oligonucleotide synthesis market owing to the presence of major pharmaceutical and biotech companies in the region. The high adoption of advanced genomic technologies and the availability of a skilled workforce for the development of novel therapeutics is further projected to help this region continue dominance during the forecast period.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Oligonucleotide synthesis Market

Product ID: SQMIG35H2107

$5,300
BUY NOW GET FREE SAMPLE